Form 8-K - Current report:
SEC Accession No. 0001193125-25-138796
Filing Date
2025-06-11
Accepted
2025-06-11 07:30:25
Documents
53
Period of Report
2025-06-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d812980d8k.htm   iXBRL 8-K 25873
2 EX-99.1 d812980dex991.htm EX-99.1 43694
6 GRAPHIC g812980ex99_1p10g1.jpg GRAPHIC 288115
7 GRAPHIC g812980ex99_1p11g1.jpg GRAPHIC 311449
8 GRAPHIC g812980ex99_1p12g1.jpg GRAPHIC 328715
9 GRAPHIC g812980ex99_1p13g1.jpg GRAPHIC 368014
10 GRAPHIC g812980ex99_1p14g1.jpg GRAPHIC 142794
11 GRAPHIC g812980ex99_1p15g1.jpg GRAPHIC 236183
12 GRAPHIC g812980ex99_1p16g1.jpg GRAPHIC 240138
13 GRAPHIC g812980ex99_1p17g1.jpg GRAPHIC 332369
14 GRAPHIC g812980ex99_1p18g1.jpg GRAPHIC 251117
15 GRAPHIC g812980ex99_1p19g1.jpg GRAPHIC 295358
16 GRAPHIC g812980ex99_1p1g1.jpg GRAPHIC 337765
17 GRAPHIC g812980ex99_1p20g1.jpg GRAPHIC 242968
18 GRAPHIC g812980ex99_1p21g1.jpg GRAPHIC 235762
19 GRAPHIC g812980ex99_1p22g1.jpg GRAPHIC 309308
20 GRAPHIC g812980ex99_1p23g1.jpg GRAPHIC 232315
21 GRAPHIC g812980ex99_1p24g1.jpg GRAPHIC 195355
22 GRAPHIC g812980ex99_1p25g1.jpg GRAPHIC 365699
23 GRAPHIC g812980ex99_1p26g1.jpg GRAPHIC 318142
24 GRAPHIC g812980ex99_1p27g1.jpg GRAPHIC 295837
25 GRAPHIC g812980ex99_1p28g1.jpg GRAPHIC 233033
26 GRAPHIC g812980ex99_1p29g1.jpg GRAPHIC 250320
27 GRAPHIC g812980ex99_1p2g1.jpg GRAPHIC 443249
28 GRAPHIC g812980ex99_1p30g1.jpg GRAPHIC 334062
29 GRAPHIC g812980ex99_1p31g1.jpg GRAPHIC 408235
30 GRAPHIC g812980ex99_1p32g1.jpg GRAPHIC 365663
31 GRAPHIC g812980ex99_1p33g1.jpg GRAPHIC 285033
32 GRAPHIC g812980ex99_1p34g1.jpg GRAPHIC 235225
33 GRAPHIC g812980ex99_1p35g1.jpg GRAPHIC 262719
34 GRAPHIC g812980ex99_1p36g1.jpg GRAPHIC 237075
35 GRAPHIC g812980ex99_1p37g1.jpg GRAPHIC 297741
36 GRAPHIC g812980ex99_1p38g1.jpg GRAPHIC 265373
37 GRAPHIC g812980ex99_1p39g1.jpg GRAPHIC 227217
38 GRAPHIC g812980ex99_1p3g1.jpg GRAPHIC 344799
39 GRAPHIC g812980ex99_1p40g1.jpg GRAPHIC 365159
40 GRAPHIC g812980ex99_1p4g1.jpg GRAPHIC 253352
41 GRAPHIC g812980ex99_1p5g1.jpg GRAPHIC 305769
42 GRAPHIC g812980ex99_1p6g1.jpg GRAPHIC 333406
43 GRAPHIC g812980ex99_1p7g1.jpg GRAPHIC 247371
44 GRAPHIC g812980ex99_1p8g1.jpg GRAPHIC 379718
45 GRAPHIC g812980ex99_1p9g1.jpg GRAPHIC 240653
  Complete submission text file 0001193125-25-138796.txt   16245233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA antx-20250611.xsd EX-101.SCH 2874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE antx-20250611_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antx-20250611_pre.xml EX-101.PRE 11723
55 EXTRACTED XBRL INSTANCE DOCUMENT d812980d8k_htm.xml XML 3759
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41331 | Film No.: 251038777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)